Literature DB >> 2893906

Specificity of iodobenzylguanidine scanning in neuroblastoma.

J Pritchard, I Gordon, L Lashford, C Dicks-Mireaux.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2893906     DOI： 10.1016/s0140-6736(88)91279-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  131I-metaiodobenzylguanidine (mIBG) for bronchial oat cell cancer and melanoma detection?

Authors:  A Osei-Bonsu; E M Kokoschka; W Ulrich; H Sinzinger
Journal:  Eur J Nucl Med       Date:  1989

Review 2.  123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.

Authors:  Gitta Bleeker; Godelieve A M Tytgat; Judit A Adam; Huib N Caron; Leontien C M Kremer; Lotty Hooft; Elvira C van Dalen
Journal:  Cochrane Database Syst Rev       Date:  2015-09-29

3.  Metastatic neuroblastoma: new abnormalities on bone scintigraphy may not indicate tumour recurrence.

Authors:  M A Hall-Craggs; D Shaw; J Pritchard; I Gordon
Journal:  Skeletal Radiol       Date:  1990       Impact factor: 2.199

4.  Short duration, high dose, alternating chemotherapy in metastatic neuroblastoma. (ENSG 3C induction regimen). The European Neuroblastoma Study Group.

Authors:  C R Pinkerton; J M Zucker; O Hartmann; J Pritchard; V Broadbent; P Morris-Jones; F Breatnach; A E Craft; A D Pearson; K R Wallendszus
Journal:  Br J Cancer       Date:  1990-08       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.